Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidine.
Tiso F, In 't Hout FEM, Knops R, Kroeze LI, van Rooij A, van de Loosdrecht AA, Westers TM, Langemeijer SMC, Preudhomme C, Duployez N, Fenaux P, Kosmider O, Bouscary D, de Graaf AO, Martens JHA, van der Reijden BA, Adès L, Fontenay M, Jansen JH. Tiso F, et al. Among authors: kroeze li. Hemasphere. 2025 Jan 3;9(1):e70034. doi: 10.1002/hem3.70034. eCollection 2025 Jan. Hemasphere. 2025. PMID: 39760001 Free PMC article. No abstract available.
Ipilimumab with nivolumab in molecularly selected patients with castration-resistant prostate cancer: primary analysis of the phase II INSPIRE trial.
van Wilpe S, Kloots ISH, Slootbeek PHJ, den Brok M, Westdorp H, Franken MD, Coskunturk M, Osinga T, Bloemendal H, Adema G, Smeenk RJ, Nagarajah J, van Ipenburg J, Kroeze LI, Ligtenberg MJL, Schalken J, Gerritsen WR, Mehra N. van Wilpe S, et al. Among authors: kroeze li. Ann Oncol. 2024 Dec;35(12):1126-1137. doi: 10.1016/j.annonc.2024.09.004. Epub 2024 Sep 16. Ann Oncol. 2024. PMID: 39293514 Free article. Clinical Trial.
Impact of TP53 loss-of-function alterations on the response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer patients.
Slootbeek PHJ, Luna-Velez MV, Privé BM, van der Doelen MJ, Kloots ISH, Pamidimarri Naga S, Onstenk HE, Nagarajah J, Westdorp H, van Oort IM, Kroeze LI, Schalken JA, Bloemendal HJ, Mehra N. Slootbeek PHJ, et al. Among authors: kroeze li. Theranostics. 2024 Aug 1;14(12):4555-4569. doi: 10.7150/thno.96322. eCollection 2024. Theranostics. 2024. PMID: 39239510 Free PMC article.
Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma.
Berendsen MR, van Bladel DAG, Hesius E, Berganza Irusquieta C, Rijntjes J, van Spriel AB, van der Spek E, Pruijt JFM, Kroeze LI, Hebeda KM, Croockewit S, Stevens WBC, van Krieken JHJM, Groenen PJTA, van den Brand M, Scheijen B. Berendsen MR, et al. Among authors: kroeze li. Hemasphere. 2023 Nov 1;7(11):e976. doi: 10.1097/HS9.0000000000000976. eCollection 2023 Nov. Hemasphere. 2023. PMID: 37928625 Free PMC article.
A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma.
van Bladel DAG, Stevens WBC, Kroeze LI, de Groen RAL, de Groot FA, van der Last-Kempkes JLM, Berendsen MR, Rijntjes J, Luijks JACW, Bonzheim I, van der Spek E, Plattel WJ, Pruijt JFM, de Jonge-Peeters SDPWM, Velders GA, Lensen C, van Bladel ER, Federmann B, Hoevenaars BM, Pastorczak A, van der Werff Ten Bosch J, Vermaat JSP, Nooijen PTGA, Hebeda KM, Fend F, Diepstra A, van Krieken JHJM, Groenen PJTA, van den Brand M, Scheijen B. van Bladel DAG, et al. Among authors: kroeze li. Blood Adv. 2023 Oct 10;7(19):5911-5924. doi: 10.1182/bloodadvances.2023010412. Blood Adv. 2023. PMID: 37552109 Free PMC article.
EuroClonality-NGS Recommendations for Evaluation of B-Cell Clonality Analysis by Next-Generation Sequencing: A Structured Approach with the DEPART Algorithm.
van den Brand M, Möbs M, Otto F, Kroeze LI, Gonzalez de Castro D, Stamatopoulos K, Davi F, Bravetti C, Kolijn PM, Vlachonikola E, Stewart JP, Pott C, Hummel M, Darzentas N, Langerak AW, Fend F, Groenen PJTA. van den Brand M, et al. Among authors: kroeze li. J Mol Diagn. 2023 Oct;25(10):729-739. doi: 10.1016/j.jmoldx.2023.06.011. Epub 2023 Jul 17. J Mol Diagn. 2023. PMID: 37467928 Free article.
Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting.
Mehra N, Kloots I, Vlaming M, Aluwini S, Dewulf E, Oprea-Lager DE, van der Poel H, Stoevelaar H, Yakar D, Bangma CH, Bekers E, van den Bergh R, Bergman AM, van den Berkmortel F, Boudewijns S, Dinjens WNM, Fütterer J, van der Hulle T, Jenster G, Kroeze LI, van Kruchten M, van Leenders G, van Leeuwen PJ, de Leng WWJ, van Moorselaar RJA, Noordzij W, Oldenburg RA, van Oort IM, Oving I, Schalken JA, Schoots IG, Schuuring E, Smeenk RJ, Vanneste BGL, Vegt E, Vis AN, de Vries K, Willemse PM, Wondergem M, Ausems M. Mehra N, et al. Among authors: kroeze li. Eur Urol Open Sci. 2023 Jan 25;49:23-31. doi: 10.1016/j.euros.2022.11.011. eCollection 2023 Mar. Eur Urol Open Sci. 2023. PMID: 36874601 Free PMC article.
47 results